Regulatory News

Curated regulatory news and analysis to keep your business informed.

View all news
Laboratory researchers in a biomedical lab
10 April 2026

SUPER BUGS Act 2026 Signals New Global Strategy for Pandemic Product Development

The SUPER BUGS Act 2026 establishes a global framework for pandemic product development, targeting antimicrobial resistance and international collaboration. It introduces regulatory, commercial, and supply chain implications for chemicals and manufacturing stakeholders, reinforcing the need for proactive compliance and strategic positioning.

Crop seedlings in soil
10 April 2026

Engineered Biofertilizers Face Regulatory Uncertainty as GAO Flags U.S. Policy Gaps

Engineered biofertilizers offer cost, yield, and environmental benefits but face regulatory ambiguity in the U.S. Clarifying definitions and frameworks will be essential to unlock innovation, ensure compliance, and maintain competitiveness in a growing global market.

Industrial chemical plant
10 April 2026

EPA PFAS Reporting Rule Delay Extends Compliance Timeline to 2027

The EPA has delayed the PFAS reporting start date to 2027, giving industry more time to prepare for TSCA compliance. While easing short-term pressure, the rule maintains extensive reporting obligations, requiring companies to strengthen data systems and supply chain transparency ahead of enforcement.

Agricultural spraying equipment in a crop field
10 April 2026

Glyphosate regulation calls intensify after Seattle public health statement

The Seattle Statement intensifies calls for stricter glyphosate regulation, citing strong evidence of cancer and systemic health risks. It urges immediate policy action, improved risk assessment, and reduced pesticide reliance, signalling significant compliance and innovation challenges across the chemicals and agricultural sectors.

European policy meeting room
10 April 2026

REACH Committee Reviews Lead, Chromium VI and CMR Measures

The February 2026 REACH Committee meeting focused on reviewing draft restrictions and authorisations for lead, chromium VI and CMR substances. While no major measures were finalised, the discussions indicate continued regulatory scrutiny and signal important developments ahead of expected votes in April.

Laboratory researchers in a biomedical lab
10 April 2026

SUPER BUGS Act 2026 Signals New Global Strategy for Pandemic Product Development

The SUPER BUGS Act 2026 establishes a global framework for pandemic product development, targeting antimicrobial resistance and international collaboration. It introduces regulatory, commercial, and supply chain implications for chemicals and manufacturing stakeholders, reinforcing the need for proactive compliance and strategic positioning.

Crop seedlings in soil
10 April 2026

Engineered Biofertilizers Face Regulatory Uncertainty as GAO Flags U.S. Policy Gaps

Engineered biofertilizers offer cost, yield, and environmental benefits but face regulatory ambiguity in the U.S. Clarifying definitions and frameworks will be essential to unlock innovation, ensure compliance, and maintain competitiveness in a growing global market.

More news

Crop spraying in California farmland

California PFAS Pesticide Ban Proposal Sets 2030 and 2035 Phase-Out Deadlines

California lawmakers have introduced AB 1603, a sweeping PFAS regulation targeting pesticides, with progressive restrictions and a full ban by 2035.

Read article
EU institutional buildings in Brussels

EU Water Policy Update Targets PFAS and Pharmaceuticals in Major Directive Revision

Laboratory glassware on a bench in a scientific setting

Australia Opens Consultation on IChEMS Proposed Standards for Industrial Chemicals

US chemical plant with industrial equipment

TSCA Reform Proposals Target Predictability and Supply Chain Resilience in US Chemicals Policy

View all news

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX